# Cyclarity Therapeutics, Inc. — Form D

Cyclarity Therapeutics, Inc. of Novato, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-30. The offering totals $12.8M, of which $10.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-12-30
- Form: D
- Accession: 0001794705-24-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.8M
- Amount sold: $10.3M
- Remaining: $2.5M
- Investors: 19
- Date of first sale: 2024-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-533653

## Issuer

- Name: Cyclarity Therapeutics, Inc.
- CIK: 0001794705
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 8001 Redwood Blvd, Novato, CA, 94945
- Phone: 6509065631

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Michael Kope | Director | Novato, CA |
| Matthew O'Connor | Director | Austin, TX |
| Michael Kope | Executive Officer | Novato, CA |
| Matthew O'Connor | Executive Officer | Austin, TX |
| Frank Schueler | Director | Mountain View, CA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-09-07](https://search.stillhousedata.com/formd/0001794705-21-000002) | D | $10.0M | $3.5M |
| [2019-11-25](https://search.stillhousedata.com/formd/0001794705-19-000001) | D | $4.0M | $1.5M |

## More

- [CIK 1794705 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1794705&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001794705-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.